These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. Viardot A; Sze L; Purtell L; Sainsbury A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV J Clin Endocrinol Metab; 2010 Jul; 95(7):3392-9. PubMed ID: 20444923 [TBL] [Abstract][Full Text] [Related]
3. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955 [TBL] [Abstract][Full Text] [Related]
4. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Lloret-Linares C; Faucher P; Coupaye M; Alili R; Green A; Basdevant A; Clément K; Poitou C Int J Obes (Lond); 2013 Sep; 37(9):1198-203. PubMed ID: 23318724 [TBL] [Abstract][Full Text] [Related]
5. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815 [TBL] [Abstract][Full Text] [Related]
6. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Schuster DP; Osei K; Zipf WB Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285 [TBL] [Abstract][Full Text] [Related]
7. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130 [TBL] [Abstract][Full Text] [Related]
8. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. Caixàs A; Giménez-Palop O; Giménez-Pérez G; Potau N; Berlanga E; González-Glemente JM; Arroyo J; Laferrère B; Mauricio D Horm Res; 2006; 65(1):39-45. PubMed ID: 16374018 [TBL] [Abstract][Full Text] [Related]
9. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome. Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437 [TBL] [Abstract][Full Text] [Related]
10. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Kennedy L; Bittel DC; Kibiryeva N; Kalra SP; Torto R; Butler MG Int J Obes (Lond); 2006 Feb; 30(2):382-7. PubMed ID: 16231029 [TBL] [Abstract][Full Text] [Related]
12. Irisin levels in genetic and essential obesity: clues for a potential dual role. Mai S; Grugni G; Mele C; Vietti R; Vigna L; Sartorio A; Aimaretti G; Scacchi M; Marzullo P Sci Rep; 2020 Jan; 10(1):1020. PubMed ID: 31974460 [TBL] [Abstract][Full Text] [Related]
13. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome. Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398 [No Abstract] [Full Text] [Related]
14. Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity? Bedogni G; Grugni G; Tringali G; Marazzi N; Sartorio A J Endocrinol Invest; 2015 Sep; 38(9):957-61. PubMed ID: 25840793 [TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome. Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902 [TBL] [Abstract][Full Text] [Related]
16. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. Haqq AM; Muehlbauer MJ; Newgard CB; Grambow S; Freemark M J Clin Endocrinol Metab; 2011 Jan; 96(1):E225-32. PubMed ID: 20962018 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968 [TBL] [Abstract][Full Text] [Related]
18. Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Butler MG; Theodoro MF; Bittel DC; Donnelly JE Am J Med Genet A; 2007 Mar; 143A(5):449-59. PubMed ID: 17103434 [TBL] [Abstract][Full Text] [Related]
19. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. van Mil EA; Westerterp KR; Gerver WJ; Curfs LM; Schrander-Stumpel CT; Kester AD; Saris WH Am J Clin Nutr; 2000 Mar; 71(3):752-6. PubMed ID: 10702169 [TBL] [Abstract][Full Text] [Related]
20. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]